Contact Us: 734-712-3456
Treatment   Cardiology
Trial Title   SAVOR Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus
Description of Research   The purpose of this study is to see if adding saxagliptin to the other medications patients are currently taking for diabetes can reduce the risk of cardiovascular disease.
Study Number   HSR-10-1101
Inclusion/Notes   For patients with documented type 2 diabetes mellitus and either have a history of previous cardiovascular events or multiple risk factors for vascular disease.
Principal Investigator   Mansoor A. Qureshi, MD
Contact Name   Carol Ames,RN
Phone   (734) 712-8252